Taken together, infiltration of CD163+ and CD68+ macrophages into TS, but not TN, is of clinical relevance for breast cancer patients and highlights the importance of analyzing the localization rather than merely the presence of TAMs as a prognostic marker. Here, CD163 is linked to breast cancer.